Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Dural arteriovenous malformation in a child with Bannayan-Riley-Ruvalcaba Syndrome.

Srinivasa RN, Burrows PE.

AJNR Am J Neuroradiol. 2006 Oct;27(9):1927-9.

2.

Cerebral venous malformations have distinct genetic origin from cerebral cavernous malformations.

Guclu B, Ozturk AK, Pricola KL, Seker A, Ozek M, Gunel M.

Stroke. 2005 Nov;36(11):2479-80. Epub 2005 Oct 20.

3.

The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis.

Hamada K, Sasaki T, Koni PA, Natsui M, Kishimoto H, Sasaki J, Yajima N, Horie Y, Hasegawa G, Naito M, Miyazaki J, Suda T, Itoh H, Nakao K, Mak TW, Nakano T, Suzuki A.

Genes Dev. 2005 Sep 1;19(17):2054-65. Epub 2005 Aug 17.

4.

Arteriovenous malformations in Cowden syndrome.

Turnbull MM, Humeniuk V, Stein B, Suthers GK.

J Med Genet. 2005 Aug;42(8):e50.

5.

Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations.

Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, Miles JH, Wang CH, Stratton R, Pilarski R, Eng C.

J Med Genet. 2005 Apr;42(4):318-21.

6.

Brain magnetic resonance imaging in patients with Cowden syndrome.

Lok C, Viseux V, Avril MF, Richard MA, Gondry-Jouet C, Deramond H, Desfossez-Tribout C, Courtade S, Delaunay M, Piette F, Legars D, Dreno B, Saïag P, Longy M, Lorette G, Laroche L, Caux F; Cancerology Group of the French Society of Dermatology.

Medicine (Baltimore). 2005 Mar;84(2):129-36.

7.

The biology and clinical relevance of the PTEN tumor suppressor pathway.

Sansal I, Sellers WR.

J Clin Oncol. 2004 Jul 15;22(14):2954-63. Review.

PMID:
15254063
8.
9.

Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases.

Hendriks YM, Verhallen JT, van der Smagt JJ, Kant SG, Hilhorst Y, Hoefsloot L, Hansson KB, van der Straaten PJ, Boutkan H, Breuning MH, Vasen HF, Bröcker-Vriends AH.

Fam Cancer. 2003;2(2):79-85.

PMID:
14574156
10.

Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.

Zhou XP, Waite KA, Pilarski R, Hampel H, Fernandez MJ, Bos C, Dasouki M, Feldman GL, Greenberg LA, Ivanovich J, Matloff E, Patterson A, Pierpont ME, Russo D, Nassif NT, Eng C.

Am J Hum Genet. 2003 Aug;73(2):404-11. Epub 2003 Jul 3.

11.

Magnetic resonance of vascular anomalies.

Konez O, Burrows PE.

Magn Reson Imaging Clin N Am. 2002 May;10(2):363-88, vii. Review.

PMID:
12424951
12.

Adipose tissue mass can be regulated through the vasculature.

Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, Folkman MJ.

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10730-5. Epub 2002 Jul 29.

13.

PTEN mutation in a family with Cowden syndrome and autism.

Goffin A, Hoefsloot LH, Bosgoed E, Swillen A, Fryns JP.

Am J Med Genet. 2001 Aug 8;105(6):521-4.

PMID:
11496368
14.

Arteriovenous malformation in a patient with Bannayan--Zonana syndrome.

Naidich JJ, Rofsky NM, Rosen R, Karp N.

Clin Imaging. 2001 Mar-Apr;25(2):130-2.

PMID:
11483425
15.

The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome.

Parisi MA, Dinulos MB, Leppig KA, Sybert VP, Eng C, Hudgins L.

J Med Genet. 2001 Jan;38(1):52-8. No abstract available.

16.
17.

Soft-tissue vascular anomalies: utility of US for diagnosis.

Paltiel HJ, Burrows PE, Kozakewich HP, Zurakowski D, Mulliken JB.

Radiology. 2000 Mar;214(3):747-54.

PMID:
10715041
18.

Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.

Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y, Dixon JE, Pandolfi P, Pavletich NP.

Cell. 1999 Oct 29;99(3):323-34.

19.

PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.

Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, Bodurtha J, Crowe C, Curtis MA, Dasouki M, Dunn T, Feit H, Geraghty MT, Graham JM Jr, Hodgson SV, Hunter A, Korf BR, Manchester D, Miesfeldt S, Murday VA, Nathanson KL, Parisi M, Pober B, Romano C, Eng C, et al.

Hum Mol Genet. 1999 Aug;8(8):1461-72.

20.

Diagnostic imaging in the evaluation of vascular birthmarks.

Burrows PE, Laor T, Paltiel H, Robertson RL.

Dermatol Clin. 1998 Jul;16(3):455-88. Review.

PMID:
9704205
Items per page

Supplemental Content

Write to the Help Desk